Bristol Myers Squibb has agreed to spend at least $100 million to expand a partnership aimed at creating RNA-based medicines for cardiovascular diseases. The deal, announced Tuesday, shows Bristol Myers is willing to bet more on drugmaking technology developed by Avidity Biosciences. Founded in 2012, Avidity is trying to combine elements from two kinds of […]
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb (NYSE: BMY) focused on the discovery, development and commercialization of multiple cardiovascular targets with potential cumulative payments of up to $2.3 […]
According to the American Heart Association (AHA), staying adequately hydrated is one of the key pillars for maintaining a strong and healthy heart and cardiovascular system. In fact, studies show that chronic dehydration can be associated with heart failure and other complications. To that end, we’re always open to delicious ways to keep our hydration […]
Bristol Myers Squibb seems to have found a friend in Avidity Biosciences, as the two add a second link to a heart-focused research partnership for $100 million upfront. The two companies tied the first deal in 2021, when Avidity announced a research collaboration with BMS-owned MyoKardia. The pact focused on discovering if Avidity’s antibody oligonucleotide […]
Avidity to receive $100 million up front with the potential to receive up to $2.2 billion in milestone payments and up to low double-digit royalties Global licensing and research collaboration to focus on discovery, development and commercialization of up to five cardiovascular targets leveraging Avidity’s proprietary AOC platform technology SAN DIEGO, Nov. 28, 2023 /PRNewswire/ […]
Share on PinterestExperts say air pollution can affect people who live near freeways. Amos Chapple/Stocksy Traffic-related air pollution was associated with a significant increase in blood pressure among car passengers, a study finds. Researchers report that the blood pressure increase is on par with other cardiovascular risk factors such as lack of exercise or excessive […]
Introduction Hypertension is one of the main preventable cardiovascular (CV) risk factors all over the years, closely related to CV morbidity and mortality. Despite numerous attempts from the scientific community and awareness programs, the prevalence is still extremely high globally.1 In the United States, nearly half of the adults (47%) have hypertension, defined either as […]
VIENTIANE, Nov. 28 (Xinhua) — Medical professionals from around the world met in the Lao capital of Vientiane to discuss cardiovascular diseases, aiming to driving advances in medical frontiers and promote international cooperation, local media reported. The inaugural Vientiane International Cardiovascular Disease Academic Exchange Conference, held in Vientiane on Saturday, was organized by the Lao […]
Imagen: Los investigadores han desarrollado un nuevo instrumento para la medicina de precisión en la enfermedad cardiovascular (Fotografía cortesía de la Universidad de Uppsala) Las enfermedades cardiovasculares, que afectan al corazón y a los vasos sanguíneos, siguen siendo la principal causa de muerte a nivel mundial. El tratamiento médico de estas enfermedades suele implicar costes […]
image: Guadalupe Sabio, Rafael Romero, Juan Antonio López, Alfonso Mora, Francisco Miguel Cruz, José Jalife, Luis Guillermo Leiva, Jesús Vázquez y Marta León. view more Credit: CNIC A study led by Guadalupe Sabio and José Jalife at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid has identified a new signaling mechanism implicated in the […]